213 results
Keyword Cefotaxime Ibi Remove keyword
-
List item
National expert: Irene Bidault, National Agency For The Safety Of Medicine And Health Products (updated)
- Declaration of interests - 39.56 KB | PDF
- Curriculum Vitae - 34.84 KB | PDF
PDF icon application/pdf ibidault_CV_en.pdf Declaration of interests … PDF icon application/pdf ibidault_DI_en.pdf … -
List item
Human medicine European public assessment report (EPAR): Tagrisso (updated)
osimertinib mesilate, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 01/02/2016,
, Revision: 19, Authorised, Last updated: 20/11/2023
adult patients with stage IB-IIIA non-small cell lung cancer … adult patients with stage IB-IIIA non-small cell lung cancer … -
List item
Orphan designation: Acetylleucine for: Treatment of GM2 gangliosidosis
Date of designation: 12/12/2017, Positive, Last updated: 25/04/2019acetylleucine (also known as IBI1000) for the treatment of GM2 … acetylleucine (also known as IBI1000) for the treatment of GM2 … -
List item
Press release: Two new medicines for advanced kidney cancer
CHMP, Last updated: 22/07/2016recommendation is based is a Phase Ib/II trial involving 153 patients … complement data from the phase Ib/II trial. The opinions adopted … recommendation is based is a Phase Ib/II trial involving 153 patients … -
List item
Availability of critical medicines before and during crises (new)
Last updated: 07/11/2023clarithromycin ceftriaxone cefotaxime piperacillin-tazobactam The …
-
List item
National expert: Anna Wachnik-Święcicka, Office For Registration Of Medicinal Products Medical Devices And Biocidal Products (updated)
- Declaration of interests - 39.52 KB | PDF
- Curriculum Vitae - 27.65 KB | PDF
infants2_12 months old (ibid.). 3. Wachnik A., Nagy K … zsiranyagcserere, patkanyban (ibid.). 8. Biro L., Rodics K … aktiyitasara patkany szerumban (ibid.). 11. Antal M., Wachnik … -
List item
National expert: Geert Molenberghs, European Medicines Agency (updated)
- Declaration of interests - 44 KB | PDF
- Curriculum Vitae - 168.39 KB | PDF
members of our department (I_BioStat) at Hasselt University and … -
List item
National expert: Javier Espíldora Hernández, European Medicines Agency (updated)
- Declaration of interests - 111.5 KB | PDF
- Curriculum Vitae - 27.12 KB | PDF
GENES Memberships Member of the IBIMA Training Commission (Institute … Comisión de Formación IBIMA (Instituto de Investigación … -
List item
National expert: Edurne Lazaro, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 39.31 KB | PDF
- Curriculum Vitae - 30.61 KB | PDF
-
List item
News: European Health Union: EU steps up action to prevent shortages of antibiotics for next winter
Last updated: 17/07/2023clarithromycin, ceftriaxone, cefotaxime and piperacillin-tazobactam … -
List item
National expert: Valentina Di Giovanni, Italian Medicines Agency (updated)
- Declaration of interests - 39.42 KB | PDF
- Curriculum Vitae - 28.92 KB | PDF
company belonging to the IBIGEN group) • Start date: 122007 • … company belonging to the IBIGEN group) • Start date: 062004 • … -
List item
Human medicine European public assessment report (EPAR): Fetcroja (updated)
cefiderocol sulfate tosilate, Gram-Negative Bacterial Infections
Date of authorisation: 23/04/2020,
, Revision: 7, Authorised, Last updated: 21/11/2023
-
List item
Human medicine European public assessment report (EPAR): Wakix (updated)
pitolisant, Narcolepsy
Date of authorisation: 31/03/2016,, 
, Revision: 15, Authorised, Last updated: 20/11/2023
-
List item
Veterinary medicine European public assessment report (EPAR): CaniLeish
Leishmania infantum excreted secreted proteins, Dogs
Date of authorisation: 14/03/2011, Revision: 2, Withdrawn, Last updated: 24/10/2023 -
List item
Human medicine European public assessment report (EPAR): Tecentriq (updated)
atezolizumab, Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung; Urologic Neoplasms; Breast Neoplasms; Small Cell Lung Carcinoma
Date of authorisation: 20/09/2017, Revision: 23, Authorised, Last updated: 20/11/2023 -
List item
Human medicine European public assessment report (EPAR): Poteligeo
Mogamulizumab, Sezary Syndrome; Mycosis Fungoides
Date of authorisation: 22/11/2018,, Revision: 6, Authorised, Last updated: 06/09/2023
-
List item
Human medicine European public assessment report (EPAR): Tepmetko (updated)
Tepotinib hydrochloride monohydrate, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 16/02/2022,, Revision: 2, Authorised, Last updated: 20/11/2023
-
List item
Human medicine European public assessment report (EPAR): Kisqali (updated)
ribociclib succinate, Breast Neoplasms
Date of authorisation: 22/08/2017, Revision: 14, Authorised, Last updated: 20/11/2023 -
List item
Human medicine European public assessment report (EPAR): Supemtek
Influenza A virus subtype H1N1 haemagglutinin, recombinant, Influenza A virus subtype H3N2 haemagglutinin, recombinant, Influenza B virus Victoria lineage haemagglutinin, recombinant, Influenza B virus Yamagata lineage haemagglutinin, recombinant, Influenza, Human
Date of authorisation: 16/11/2020,, Revision: 3, Authorised, Last updated: 26/07/2023
-
List item
Human medicine European public assessment report (EPAR): Opdivo
nivolumab, Melanoma; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Urologic Neoplasms; Mesothelioma; Colorectal Neoplasms
Date of authorisation: 19/06/2015, Revision: 56, Authorised, Last updated: 30/10/2023 -
List item
National expert: Inmaculada Corrales, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 39.23 KB | PDF
- Curriculum Vitae - 35.13 KB | PDF
-
List item
National expert: Christian Mayer, Austrian Agency for Health and Food Safety (updated)
- Declaration of interests - 39.21 KB | PDF
- Curriculum Vitae - 26.47 KB | PDF
cyanobacterial cytochrome c oxidase. Ibidem pp.341_355 Projects Memberships Other … -
List item
National expert: Guoda Radaviciute, State Medicines Control Agency (updated)
- Declaration of interests - 39.22 KB | PDF
- Curriculum Vitae - 25.65 KB | PDF
evaluation of variations of type IB/IA and type II. Evaluation of … -
List item
Human medicine European public assessment report (EPAR): Ledaga
Chlormethine, Mycosis Fungoides
Date of authorisation: 03/03/2017,, Revision: 9, Authorised, Last updated: 11/09/2023
-
List item
Human medicine European public assessment report (EPAR): Lenalidomide Mylan
lenalidomide, Multiple Myeloma
Date of authorisation: 18/12/2020,
, Revision: 8, Authorised, Last updated: 12/07/2023